$ cat ./records/delivered-global-health-address-at-world-economic-forum-annual-me-2001.txt
Delivered global health address at World Economic Forum Annual Meeting
[RECORD.TXT] · cat --full
Gates delivered a major speech at the World Economic Forum in Davos outlining the Gates Foundation's strategic priorities — global vaccines, tuberculosis, HIV/AIDS, and maternal health — and making the case for philanthropic capital to fill gaps that markets and government aid were leaving in global public health. The speech established Gates as a leading voice at Davos on development issues and began his long-running annual presence at the forum, bridging the technology, business, and global health communities.
Source: https://gatesfoundation.org/Media-Center/Speeches/2001/01/Bill-Gates-2001-World-Economic-Forum
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
D.C. Circuit Court of Appeals overturns Microsoft breakup order — major legal reversal
Next →
Launched the Xbox gaming console
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.